168,166 Shares in Teladoc Health, Inc. (NYSE:TDOC) Acquired by Jennison Associates LLC

Jennison Associates LLC bought a new position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 168,166 shares of the health services provider's stock, valued at approximately $1,544,000. Jennison Associates LLC owned about 0.10% of Teladoc Health as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Clearline Capital LP boosted its position in Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock valued at $42,682,000 after acquiring an additional 3,483,665 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Teladoc Health by 195.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider's stock valued at $932,000 after purchasing an additional 63,028 shares in the last quarter. Mackenzie Financial Corp grew its stake in Teladoc Health by 170.7% during the second quarter. Mackenzie Financial Corp now owns 107,255 shares of the health services provider's stock worth $1,049,000 after purchasing an additional 67,640 shares during the period. Point72 Asset Management L.P. lifted its stake in Teladoc Health by 221.9% in the second quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider's stock valued at $51,865,000 after buying an additional 3,655,436 shares during the period. Finally, Granite Bay Wealth Management LLC bought a new position in shares of Teladoc Health during the 2nd quarter worth approximately $1,111,000. Institutional investors own 76.82% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft increased their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a "hold" rating in a research note on Friday, November 1st. Truist Financial decreased their target price on Teladoc Health from $15.00 to $10.00 and set a "hold" rating for the company in a research report on Friday, August 2nd. Royal Bank of Canada increased their price target on Teladoc Health from $9.00 to $10.00 and gave the stock an "outperform" rating in a report on Wednesday, October 9th. Stifel Nicolaus decreased their price objective on Teladoc Health from $16.00 to $9.00 and set a "hold" rating for the company in a report on Thursday, August 1st. Finally, JPMorgan Chase & Co. cut their target price on Teladoc Health from $16.00 to $9.00 and set a "neutral" rating on the stock in a report on Monday, August 26th. Fourteen analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Teladoc Health presently has an average rating of "Hold" and a consensus price target of $12.08.

Insider Activity at Teladoc Health

In related news, COO Michael Willem Waters sold 4,218 shares of Teladoc Health stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $30,200.88. Following the completion of the transaction, the chief operating officer now directly owns 78,309 shares in the company, valued at approximately $560,692.44. The trade was a 5.11 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Thomas Mckinley bought 4,000 shares of the stock in a transaction on Thursday, September 12th. The shares were acquired at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the acquisition, the director now directly owns 39,077 shares in the company, valued at approximately $300,502.13. This trade represents a 11.40 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 20,051 shares of company stock worth $143,565. Insiders own 0.95% of the company's stock.

Teladoc Health Stock Performance

Teladoc Health stock traded up $0.22 during mid-day trading on Friday, reaching $10.62. 6,991,601 shares of the company's stock were exchanged, compared to its average volume of 6,525,687. The business's fifty day simple moving average is $9.10 and its 200 day simple moving average is $9.25. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a one year low of $6.76 and a one year high of $22.54. The firm has a market capitalization of $1.83 billion, a PE ratio of -1.84 and a beta of 0.90.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to analysts' expectations of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, sell-side analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.